Andrea Pfeifer
Founder at AC IMMUNE SA
Net worth: 6 M $ as of 2024-04-29
Profile
Dr. Andrea Pfeifer is an Independent Member-Supervisory Board at Symrise AG, a Chief Executive Officer & Director at AC Immune SA, a Chairman at AB2 Bio SA, a Chairman at BioMedInvest AG I and a Professor at University of Lausanne.
She is on the Board of Directors at Symrise AG and AC Immune SA. Dr. Pfeifer was previously employed as a Chairman by BioMedPartners AG, a Head-Global Research by Nestlé Nespresso SA, a Member-Supervisory Board by 4basebio AG, a Founder by Inventages II, and a Principal by Nestlé USA, Inc. She received her doctorate degree from Wuerzburg Schweinfurt University of Applied Sciences.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AC IMMUNE SA
2.44% | 2024-02-29 | 2,421,226 ( 2.44% ) | 6 M $ | 2024-04-29 |
Andrea Pfeifer active positions
| Companies | Position | Start |
|---|---|---|
| AC IMMUNE SA | Founder | 2003-02-12 |
| SYMRISE AG | Director/Board Member | 2011-04-30 |
| University of Lausanne | Corporate Officer/Principal | - |
BioMedInvest AG I
 BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Chairman | - |
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Chairman | - |
Former positions of Andrea Pfeifer
| Companies | Position | End |
|---|---|---|
| 2INVEST AG | Director/Board Member | 2012-10-17 |
Nestlé Nespresso SA
 Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
Inventages II
 Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Founder | - |
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Chairman | - |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Andrea Pfeifer
| Wuerzburg Schweinfurt University of Applied Sciences | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AC IMMUNE SA | Health Technology |
| 2INVEST AG | Finance |
| SYMRISE AG | Process Industries |
| Private companies | 6 |
|---|---|
Nestlé USA, Inc.
 Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Nestle USA, Inc. produces dairy and bakery products. Its products include chocolate and confectionaries, beverages, ice cream, juices, milk products, pet food, prepared foods, and sports nutrition. The company is headquartered in Arlington, VA. | Process Industries |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Finance |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Finance |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
Inventages II
Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Finance |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Producer Manufacturing |
- Stock Market
- Insiders
- Andrea Pfeifer
